Design, synthesis, biological evaluation and docking analysis of pyrrolidine-benzenesulfonamides as carbonic anhydrase or acetylcholinesterase inhibitors and antimicrobial agents

References

• Abbas, H. A., & Wierda, W. G. (2021). Acalabrutinib: A selective Bruton tyrosine kinase inhibitor for the treatment of B-cell malignancies. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.668162
   Web of Science ®Google Scholar
• Accelrys Software Inc. (2013). Discovery studio modeling environment. Release 3.5 Accelrys Software Inc, San Diego
   Google Scholar
• Amani Shafeek Awaad AMAA, Reham Mostafa, & El-Meligy (2017). Amino substituted acetamide derivative. US 9,598,361 BI. King Saud University;
   Google Scholar
• Anand, P., & Singh, B. (2013). A review on cholinesterase inhibitors for Alzheimer’s disease. Archives of Pharmacological Research, 36(4), 375–399. https://doi.org/10.1007/s12272-013-0036-3
   PubMed Web of Science ®Google Scholar
• Angeli, A., Ferraroni, M., Nocentini, A., Selleri, S., Gratteri, P., Supuran, C. T., & Carta, F. (2019). Polypharmacology of epacadostat: A potent and selective inhibitor of the tumor associated carbonic anhydrases IX and XII. Chemical Communications (Cambridge, England), 55(40), 5720–5723. https://doi.org/10.1039/c8cc09568j
   PubMed Web of Science ®Google Scholar
• Arslan, S., Loğoğlu, E., & Oktemer, A. (2006). Antimicrobial activity studies on some piperidine and pyrrolidine substituted halogenobenzene derivatives. Journal of Enzyme Inhibition & Medicinal Chemistry, 21(2), 211–214. https://doi.org/10.1080/14756360600563063
   PubMed Web of Science ®Google Scholar
• Arumugam, N., Almansour, A. I., Kumar, R. S., Krishna, V. S., Sriram, D., & Dege, N. (2021). Stereoselective synthesis and discovery of novel spirooxindolopyrrolidine engrafted indandione heterocyclic hybrids as antimycobacterial agents. Bioorganic Chemistry, 110.
   PubMed Web of Science ®Google Scholar
• Askin, S., Tahtaci, H., Turkes, C., et al. (2021). Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors. Bioorganic Chemistry, 113.
   PubMed Web of Science ®Google Scholar
• Aydinoglu, S., Biver, T., Figuccia, S., Fiore, T., Montanaro, S., & Pellerito, C. (2016). Studies on DNA interaction of organotin(IV) complexes of meso-tetra(4-sulfonatophenyl)porphine that show cellular activity. Journal of Inorganic Biochemistry, 163, 311–317. https://doi.org/10.1016/j.jinorgbio.2016.06.030
   PubMed Web of Science ®Google Scholar
• Aydinoglu, S., Pasti, A., Biver, T., & Mennucci, B. (2019). Auramine O interaction with DNA: A combined spectroscopic and TD-DFT analysis. Physical Chemistry Chemical Physics: PCCP, 21(37), 20606–20612. https://doi.org/10.1039/c9cp03071a
   PubMed Web of Science ®Google Scholar
• Bank RPD RCSB PDB: Homepage. https://www.rcsb.org/
   Google Scholar
• Belveren, S., Döndas, H. A., Ülger, M., Poyraz, S., García-Mingüens, E., Ferrándiz-Saperas, M., & Sansano, J. M. (2017). Synthesis of highly functionalized 2-(pyrrolidin-1-yl)thiazole frameworks with interesting antibacterial and antimycobacterial activity. Tetrahedron, 73(48), 6718–6727. https://doi.org/10.1016/j.tet.2017.10.007
   Web of Science ®Google Scholar
• Belveren, S., Larrañaga, O., Poyraz, S., Döndas, H. A., Ülger, M., Şahin, E., Ferrándiz-Saperas, M., Sansano, J., de Gracia Retamosa, M., & de Cózar, A. (2019). From bioactive pyrrolidino[3,4-c] pyrrolidines to more bioactive pyrrolidino[3,4-b] pyrrolidines via ring-opening/ring-closing promoted by sodium methoxide. Synthesis, 51(07), 1565–1577. https://doi.org/10.1055/s-0037-1611356
   Google Scholar
• Bongomin, F., Gago, S., Oladele, R. O., & Denning, D. W. (2017). Global and multi-national prevalence of fungal diseases-estimate precision. Journal of Fungi, 3(4).
   Web of Science ®Google Scholar
• Caglayan, C., Taslimi, P., Demir, Y., Kucukler, S., Kandemir, F. M., & Gulcin, I. (2019). The effects of zingerone against vancomycin-induced lung, liver, kidney and testis toxicity in rats: The behavior of some metabolic enzymes. Journal of Biochemistry & Molecular Toxicology, 33(10).
   Web of Science ®Google Scholar
• Caglayan, C., Taslimi, P., Türk, C., Gulcin, İ., Kandemir, F. M., Demir, Y., & Beydemir, Ş. (2020). Inhibition effects of some pesticides and heavy metals on carbonic anhydrase enzyme activity purified from horse mackerel (Trachurus trachurus) gill tissues. Environmental Science & Pollution Research International, 27(10), 10607–10616. https://doi.org/10.1007/s11356-020-07611-z
   PubMed Web of Science ®Google Scholar
• Chalkha, M., Nakkabi, A., & Ben Hadda, T. (2022). Crystallographic study, biological assessment and POM/docking studies of pyrazoles-sulfonamide hybrids (PSH): Identification of a combined antibacterial/antiviral pharmacophore sites leading to in-silico screening the anti-Covid-19 activity. Journal of Molecular Structure, 1267.
   PubMed Web of Science ®Google Scholar
• Choubey, P. K., Tripathi, A., Sharma, P., & Shrivastava, S. K. (2020). Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer’s disease. Bioorganic Medicinal Chemistry, 28(22).
   PubMed Web of Science ®Google Scholar
• De Luca, V., Vullo, D., Del Prete, S., Carginale, V., Osman, S. M., AlOthman, Z., Supuran, C. T., & Capasso, C. (2016). Cloning, characterization and anion inhibition studies of a gamma-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea. Bioorganic & Medicinal Chemistry, 24(4), 835–840. https://doi.org/10.1016/j.bmc.2016.01.005
   PubMed Web of Science ®Google Scholar
• Del Prete, S., Isik, S., Vullo, D., De Luca, V., Carginale, V., Scozzafava, A., Supuran, C. T., & Capasso, C. (2012). DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. Journal of Medicinal Chemistry, 55(23), 10742–10748. https://doi.org/10.1021/jm301611m
   PubMed Web of Science ®Google Scholar
• Döndas, H. A., Retamosa, M. D., & Sansano, J. M. (2017). Current trends towards the synthesis of bioactive heterocycles and natural products using 1,3-dipolar cycloadditions (1,3-DC) with azomethine ylides. Synthesis, 49(13), 2819–2851. https://doi.org/10.1055/s-0036-1588423
   Web of Science ®Google Scholar
• Eberhardt, J., Santos-Martins, D., Tillack, A. F., & Forli, S. (2021). AutoDock Vina 1.2.0: New docking methods, expanded force field, and python bindings. Journal of Chemical Information & Modeling, 61(8), 3891-3898.
   PubMed Web of Science ®Google Scholar
• Ellman, G. L., Courtney, K. D., Andres, V., Jr., & Feather-Stone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology, 7, 88–95. https://doi.org/10.1016/0006-2952(61)90145-9
   PubMed Web of Science ®Google Scholar
• Erdogan, M. K., Gundogdu, R., Yapar, Y., Gecibesler, I. H., Kirici, M., Behcet, L., Tüzün, B., Taskin-Tok, T., & Taslimi, P. (2023). In vitro anticancer, antioxidant and enzyme inhibitory potentials of endemic Cephalaria elazigensis var. purpurea with in silico studies. Journal of Biomolecular Structure & Dynamics, 1–13. https://doi.org/10.1080/07391102.2022.2163700
   Web of Science ®Google Scholar
• Ewies, E. F., Sabry, E., Bekheit, M. S., Fouad, M. A., Vullo, D., & Supuran, C. T. (2022). Click chemistry-based synthesis of new benzenesulfonamide derivatives bearing triazole ring as selective carbonic anhydrase II inhibitors. Drug Development Research, 83(6), 1281–1291. https://doi.org/10.1002/ddr.21957
   PubMed Web of Science ®Google Scholar
• Feng, J., Qi, H., Sun, X., Feng, S., Liu, Z., Song, Y., & Qiao, X. (2018). Synthesis of novel pyrazole derivatives as promising DNA-binding agents and evaluation of antitumor and antitopoisomerases I/II activities. Chemical & Pharmaceutical Bulletin, 66(11), 1065–1071. https://doi.org/10.1248/cpb.c18-00546
   PubMed Web of Science ®Google Scholar
• Frejat, F. O. A., Cao, Y. Q., Wang, L. H., et al. (2022). New 1,2,4-oxadiazole/pyrrolidine hybrids as topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity. Archiv Der Pharmazie, 355(7).
   PubMed Web of Science ®Google Scholar
• Gahlaut, A. (2013). Evaluation of antibacterial potential of plant extracts using resazurin based microtiter dilution assay. International Journal of Pharmacy and Pharmaceutical Sciences, 5, 372–376.
   Google Scholar
• Gaussian, Revision E., Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Mennucci, B., Petersson, G. A., et. al. (2009). Gaussian, Inc.
   Google Scholar
• Gümüş, M., Babacan, Ş. N., Demir, Y., Sert, Y., Koca, İ., & Gülçin, İ. (2022). Discovery of sulfadrug-pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors. Archiv Der Pharmazie, 355(1), e2100242. https://doi.org/10.1002/ardp.202100242
   PubMed Web of Science ®Google Scholar
• Gungor, S. A., Tumer, M., Kose, M., & Erkan, S. (2022). N-substituted benzenesulfonamide compounds: DNA binding properties and molecular docking studies. Journal of Biomolecular Structure & Dynamics, 40(16), 7424–7438.
   PubMed Web of Science ®Google Scholar
• Guzeldemirci, N. U., & Kucukbasmaci, O. (2010). Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety. European Journal of Medicinal Chemistry, 45(1), 63–68. https://doi.org/10.1016/j.ejmech.2009.09.024
   PubMed Web of Science ®Google Scholar
• Hamide, M., Gok, Y., & Demir, Y. (2022). Pentafluorobenzyl-substituted benzimidazolium salts: Synthesis, characterization, crystal structures, computational studies and inhibitory properties of some metabolic enzymes. Journal of Molecular Structure, 1265.
   Web of Science ®Google Scholar
• Ibrahim, N. M., Fahim, S. H., Hassan, M., Farag, A. E., & Georgey, H. H. (2022). Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects. European Journal of Medicinal Chemistry, 228.
   PubMed Web of Science ®Google Scholar
• Javed, M. A., Bibi, S., Jan, M. S., Ikram, M., Zaidi, A., Farooq, U., Sadiq, A., & Rashid, U. (2022). Diclofenac derivatives as concomitant inhibitors of cholinesterase, monoamine oxidase, cyclooxygenase-2 and 5-lipoxygenase for the treatment of Alzheimer’s disease: Synthesis, pharmacology, toxicity and docking studies. RSC Advances, 12(35), 22503–22517. https://doi.org/10.1039/d2ra04183a
   PubMed Web of Science ®Google Scholar
• Kaya, G., Noma, S. A. A., Barut Celepci, D., Bayıl, İ., Taskin-Tok, T., Gök, Y., Ateş, B., Aktaş, A., Aygün, M., & Tezcan, B. (2023). Design, synthesis, spectroscopic characterizations, single crystal X-ray analysis, in vitro xanthine oxidase and acetylcholinesterase inhibitory evaluation as well as in silico evaluation of selenium-based N-heterocyclic carbene compounds. Journal of Biomolecular Structure & Dynamics, 1–20. https://doi.org/10.1080/07391102.2022.2163696
   Web of Science ®Google Scholar
• Kelley, B. J., & Petersen, R. C. (2007). Alzheimer’s disease and mild cognitive impairment. Neurologic Clinics, 25(3), 577–609. https://doi.org/10.1016/j.ncl.2007.03.008
   PubMed Web of Science ®Google Scholar
• Kumar, R., Kumar, A., & Ram, S. (2022). Novel benzenesulfonamide-bearing pyrazoles and 1,2,4-thiadiazoles as selective carbonic anhydrase inhibitors. Archiv Der Pharmazie. 355(1).
   Web of Science ®Google Scholar
• Larner, A. J. (2010). Cholinesterase inhibitors: Beyond Alzheimer’s disease. Expert Review of Neurotherapeutics, 10(11), 1699–1705. https://doi.org/10.1586/ern.10.105
   PubMed Web of Science ®Google Scholar
• Le Duc, Y., Licsandru, E., Vullo, D., Barboiu, M., & Supuran, C. T. (2017). Carbonic anhydrases activation with 3-amino-1H-1,2,4-triazole-1-carboxamides: Discovery of subnanomolar isoform II activators. Bioorganic & Medicinal Chemistry, 25(5), 1681–1686. https://doi.org/10.1016/j.bmc.2017.01.031
   PubMed Web of Science ®Google Scholar
• Lorthiois, E., Breitenstein, W., Cumin, F., Ehrhardt, C., Francotte, E., Jacoby, E., Ostermann, N., Sellner, H., Kosaka, T., Webb, R. L., Rigel, D. F., Hassiepen, U., Richert, P., Wagner, T., & Maibaum, J. (2013). The discovery of novel potent trans-3,4-disubstituted pyrrolidine inhibitors of the human aspartic protease renin from in silico three-dimensional (3D) pharmacophore searches. Journal of Medicinal Chemistry, 56(6), 2207–2217. https://doi.org/10.1021/jm3017078
   PubMed Web of Science ®Google Scholar
• Łowicki, D., & Przybylski, P. (2022). Tandem construction of biological relevant aliphatic 5-membered N-heterocycles. European Journal of Medicinal Chemistry, 235, 114303. https://doi.org/10.1016/j.ejmech.2022.114303
   PubMed Web of Science ®Google Scholar
• Mancuso, F., Angeli, A., De Luca, V., et al. (2022). Synthesis and biological evaluation of sulfonamide-based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae. Archiv Der Pharmazie, 355(10).
   PubMed Web of Science ®Google Scholar
• Monti, S. M., Maresca, A., Viparelli, F., Carta, F., De Simone, G., Mühlschlegel, F. A., Scozzafava, A., & Supuran, C. T. (2012). Dithiocarbamates are strong inhibitors of the beta-class fungal carbonic anhydrases from Cryptococcus neoformans, Candida albicans and Candida glabrata. Bioorganic & Medicinal Chemistry Letters, 22(2), 859–862. https://doi.org/10.1016/j.bmcl.2011.12.033
   PubMed Web of Science ®Google Scholar
• NCCLS, 940 West Valley Road, Suite 1400 (2002). Wayne, Pennsylvania 19087-1898 USA.
   Google Scholar
• NCCLS. National Committee for Clinical Laboratory Standards (2003). Susceptibility testing of Mycobacteria, Nocardia, and other aerobic actinomycetes: Approved Standard NCCLS Document M24-A. NCCLS, Wayne, Pennsylvania.
   Google Scholar
• NCCLS. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-second edition. NCCLS document M27-A2 (ISBN 1-56238-469-4).
   Google Scholar
• Nemr, M. T. M., AboulMagd, A. M., Hassan, H. M., Hamed, A. A., Hamed, M. I. A., & Elsaadi, M. T. (2021). Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents via carbonic anhydrase IX inhibition. RSC Advances, 11(42), 26241–26257. https://doi.org/10.1039/d1ra05277b
   PubMed Web of Science ®Google Scholar
• Nishimori, I., Minakuchi, T., Maresca, A., Carta, F., Scozzafava, A., & Supuran, C. T. (2010). The beta-carbonic anhydrases from Mycobacterium tuberculosis as drug targets. Current Pharmaceutical Design, 16(29), 3300–3309. https://doi.org/10.2174/138161210793429814
   PubMed Web of Science ®Google Scholar
• Nishimori, I., Onishi, S., Takeuchi, H., & Supuran, C. T. (2008). The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets. Current Pharmaceutical Design, 14(7), 622–630. https://doi.org/10.2174/138161208783877875
   PubMed Web of Science ®Google Scholar
• Nocentini, A., Moi, D., Balboni, G., Salvadori, S., Onnis, V., & Supuran, C. T. (2018). Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy. Bioorganic Chemistry, 77, 633–639. https://doi.org/10.1016/j.bioorg.2018.02.021
   PubMed Web of Science ®Google Scholar
• Osmaniye, D., Turkes, C., Demir, Y., Ozkay, Y., Beydemir, S., & Kaplancikli, Z. A. (2022). Design, synthesis, and biological activity of novel dithiocarbamate-methylsulfonyl hybrids as carbonic anhydrase inhibitors. Archiv Der Pharmazie, 355(8).
   Web of Science ®Google Scholar
• Palomino, J. C., Martin, A., Camacho, M., Guerra, H., Swings, J., & Portaels, F. (2002). Resazurin microtiter assay plate: Simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrobial Agents & Chemotherapy, 46(8), 2720–2722. https://doi.org/10.1128/AAC.46.8.2720-2722.2002
   PubMed Web of Science ®Google Scholar
• Parish, T. (2019). Steps to address anti-microbial drug resistance in today’s drug discovery. Expert Opinion on Drug Discovery, 14(2), 91–94. https://doi.org/10.1080/17460441.2019.1550481
   PubMed Web of Science ®Google Scholar
• Pourtaher, H., Hasaninejad, A., & Iraji, A. (2022). Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer’s disease. Scientific Reports, 12(1) https://doi.org/10.1038/s41598-022-18224-6
   PubMed Web of Science ®Google Scholar
• Poyraz, S., Belveren, S., Ülger, M., Şahin, E., & Döndaş, H. A. (2017). Synthesis, characterization, crystal structure, and antituberculosis activity of some novel polysubstituted aminocarbothiol/thiohydantoin-pyrrolidine derivatives. Monatshefte Für Chemie: Chemical Monthly, 148(12), 2173–2182. https://doi.org/10.1007/s00706-017-2039-0
   Google Scholar
• Poyraz, S., Canacankatan, N., Belveren, S., Yetkin, D., Kibar, K., Ülger, M., Sansano, J. M., Özcelik, N. D., Necat Yılmaz, Ş., & Döndaş, H. A. (2018). Study of the anti(myco)bacterial and antitumor activities of prolinate and N-amidocarbothiolprolinate derivatives based on fused tetrahydropyrrolo[3,4-c]pyrrole-1,3(2H,3aH)-dione, bearing an indole ring. Monatshefte Für Chemie: Chemical Monthly, 149(12), 2253–2263. https://doi.org/10.1007/s00706-018-2286-8
   Google Scholar
• Rescifina, A., Zagni, C., Varrica, M. G., Pistara, V., & Corsaro, A. (2014). Recent advances in small organic molecules as DNA intercalating agents: Synthesis, activity, and modeling. European Journal of Medicinal Chemistry, 74, 95–115. https://doi.org/10.1016/j.ejmech.2013.11.029
   PubMed Web of Science ®Google Scholar
• Saglik, B. N., Cevik, U. A., Osmaniye, D., et al. (2019). Synthesis, molecular docking analysis and carbonic anhydrase I-II inhibitory evaluation of new sulfonamide derivatives. Bioorganic Chemistry, 91.
   PubMed Web of Science ®Google Scholar
• Sever, B., Türkeş, C., Altıntop, M. D., Demir, Y., & Beydemir, Ş. (2020). Thiazolyl-pyrazoline derivatives: In vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors. International Journal of Biological Macromolecules, 163, 1970–1988. https://doi.org/10.1016/j.ijbiomac.2020.09.043
   PubMed Web of Science ®Google Scholar
• Sonmez, M., Celebi, M., & Berber, I. (2010). Synthesis, spectroscopic and biological studies on the new symmetric Schiff base derived from 2,6-diformyl-4-methylphenol with N-aminopyrimidine. European Journal of Medicinal Chemistry, 45(5), 1935–1940. https://doi.org/10.1016/j.ejmech.2010.01.035
   PubMed Web of Science ®Google Scholar
• Soyer, Z., Uysal, S., Parlar, S., Dogan, A. H. T., & Alptuzun, V. (2017). Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors. Journal of Enzyme Inhibition & Medicinal Chemistry, 32(1), 13–19. https://doi.org/10.1080/14756366.2016.1226298
   PubMed Web of Science ®Google Scholar
• Supuran, C. T. (2008). Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nature Reviews: Drug Discovery, 7(2), 168–181. https://doi.org/10.1038/nrd2467
   PubMed Web of Science ®Google Scholar
• Supuran, C. T. (2011). Bacterial carbonic anhydrases as drug targets: Toward novel antibiotics? Frontiers in Pharmacology, 2, 34. https://doi.org/10.3389/fphar.2011.00034
   PubMed Web of Science ®Google Scholar
• Supuran, C. T. (2016). How many carbonic anhydrase inhibition mechanisms exist? Journal of Enzyme Inhibition & Medicinal Chemistry, 31(3), 345–360. https://doi.org/10.3109/14756366.2015.1122001
   PubMed Web of Science ®Google Scholar
• Supuran, C. T. (2021). Novel carbonic anhydrase inhibitors. Future Medicinal Chemistry, 13(22), 1935–1937.
   PubMed Web of Science ®Google Scholar
• Supuran, C. T. (2022). Anti-obesity carbonic anhydrase inhibitors: Challenges and opportunities. Journal of Enzyme Inhibition & Medicinal Chemistry, 37(1), 2478–2488. https://doi.org/10.1080/14756366.2022.2121393
   PubMed Web of Science ®Google Scholar
• Temperini, C., Scozzafava, A., & Supuran, C. T. (2008). Carbonic anhydrase activation and the drug design. Current Pharmaceutical Design, 14(7), 708–715. https://doi.org/10.2174/138161208783877857
   PubMed Web of Science ®Google Scholar
• Tok, F., Saglik, B. N., Ozkay, Y., & Kaplancikli, Z. A. (2022). Kocyigit-Kaymakcioglu B. Design, synthesis, biological activity evaluation and in silico studies of new nicotinohydrazide derivatives as multi-targeted inhibitors for Alzheimer’s disease. Journal of Molecular Structure, 1265.
   Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. Journal of Computational Chemistry, 31, 455–461.
   PubMed Web of Science ®Google Scholar
• Trunkfield, A. E., Gurcha, S. S., Besra, G. S., & Bugg, T. D. H. (2010). Inhibition of Escherichia coli glycosyltransferase MurG and Mycobacterium tuberculosis Gal transferase by uridine-linked transition state mimics. Bioorganic & Medicinal Chemistry, 18(7), 2651–2663. https://doi.org/10.1016/j.bmc.2010.02.026
   PubMed Web of Science ®Google Scholar
• Tugrak, M., Gul, H. I., Demir, Y., Levent, S., & Gulcin, I. (2021). Synthesis and in vitro carbonic anhydrases and acetylcholinesterase inhibitory activities of novel imidazolinone-based benzenesulfonamides. Archiv Der Pharmazie, 354(4), 2000375. https://doi.org/10.1002/ardp.202000375
   PubMed Web of Science ®Google Scholar
• Türkan, F., Huyut, Z., Demir, Y., Ertaş, F., & Beydemir, Ş. (2019). The effects of some cephalosporins on acetylcholinesterase and glutathione S-transferase: An in vivo and in vitro study. Archives of Physiology & Biochemistry, 125(3), 235–243. https://doi.org/10.1080/13813455.2018.1452037
   PubMed Web of Science ®Google Scholar
• Türkeş, C., Demir, Y., & Beydemir, Ş. (2022). Some calcium-channel blockers: Kinetic and in silico studies on paraoxonase-I. Journal of Biomolecular Structure & Dynamics, 40(1), 77–85. https://doi.org/10.1080/07391102.2020.1806927
   PubMed Web of Science ®Google Scholar
• Wang, N., Liu, W., Zhou, L., Liu, W., Liang, X., Liu, X., Xu, Z., Zhong, T., Wu, Q., Jiao, X., Chen, J., Ning, X., Jiang, X., & Zhao, Q. (2022). Design, synthesis, and biological evaluation of notopterol derivatives as triple inhibitors of AChE/BACE1/GSK3 beta for the treatment of Alzheimer’s disease. ACS Omega, 7(36), 32131–32152. https://doi.org/10.1021/acsomega.2c03368
   PubMed Web of Science ®Google Scholar
• Wesołowska, A., Nikiforuk, A., Stachowicz, K., & Tatarczyńska, E. (2006). Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology, 51(3), 578–586. https://doi.org/10.1016/j.neuropharm.2006.04.017
   PubMed Web of Science ®Google Scholar
• WHO (2017). Prioritization of pathogens to guide discovery, research, and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. WHO/EMP/IAU/201712 2017.
   Google Scholar
• Yamali, C., Gul, H. I., & Ozli, G. (2021). Exploring of tumor-associated carbonic anhydrase isoenzyme IX and XII inhibitory effects and cytotoxicities of the novel N-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1H-pyrazole-3-carboxamides. Bioorganic Chemistry, 115.
   PubMed Web of Science ®Google Scholar
• Yamali, C., Gul, H. I., Cakir, T., Demir, Y., & Gulcin, I. (2020). Aminoalkylated phenolic chalcones: Investigation of biological effects on acetylcholinesterase and carbonic anhydrase I and II as potential lead enzyme inhibitors. Letters in Drug Design & Discovery, 17(10), 1283–1292. https://doi.org/10.2174/1570180817999200520123510
   Web of Science ®Google Scholar
• Yamali, C., Gul, H. I., Kazaz, C., Levent, S., & Gulcin, I. (2020). Synthesis, structure elucidation, and in vitro pharmacological evaluation of novel polyfluoro substituted pyrazoline type sulfonamides as multi-target agents for inhibition of acetylcholinesterase and carbonic anhydrase I and II enzymes. Bioorganic Chemistry, 96.
   PubMed Web of Science ®Google Scholar
• Yamali, C., Gul, H. I., Sakarya, M. T., et al. (2022a). Quinazolinone-based benzenesulfonamides with low toxicity and high affinity as monoamine oxidase-A inhibitors: Synthesis, biological evaluation and induced-fit docking studies. Bioorganic Chemistry, 124.
   PubMed Web of Science ®Google Scholar
• Yamali, C., Sakagami, H., Satoh, K., Bandow, K., Uesawa, Y., Bua, S., Angeli, A., Supuran, C. T., & Gul, H. I. (2022b). Investigation of carbonic anhydrase inhibitory effects and cytotoxicities of pyrazole-based hybrids carrying hydrazone and zinc-binding benzenesulfonamide pharmacophores. Bioorganic Chemistry, 127, 105969. https://doi.org/10.1016/j.bioorg.2022.105969
   PubMedGoogle Scholar
• Zhang, J., Pan, X., Wang, C., Wang, F., Li, P., Xu, W., & He, L. (2012). Pharmacophore modeling, 3D-QSAR studies, and in-silico ADME prediction of pyrrolidine derivatives as neuraminidase inhibitors. Chemical Biology & Drug Design, 79(3), 353–359. https://doi.org/10.1111/j.1747-0285.2011.01299.x
   PubMed Web of Science ®Google Scholar
• Zhang, P. F., Xu, S. T., Zhu, Z. Y., & Xu, J. Y. (2019). Multi-target design strategies for the improved treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry, 176, 228–247. https://doi.org/10.1016/j.ejmech.2019.05.020
   PubMed Web of Science ®Google Scholar
• Zverova, M. (2019). Clinical aspects of Alzheimer’s disease. Clinical Biochemistry, 72, 3–6.
   PubMed Web of Science ®Google Scholar